Emerging role of transforming growth factor-β-regulated long non-coding RNAs in prostate cancer pathogenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Prostate cancer (PCa) is a leading male malignancy with significant treatment challenges, including recurrence and metastatic castration-resistant prostate cancer (CRPCa).
• Transforming growth factor-β (TGF-β) signaling pathway dysregulation is integral to PCa development, progression, and the emergence of CRPCa.
• TGF-β signaling influences androgen receptor (AR) activation, a key factor in CRPCa development.

Purpose of the Study:

• To explore the intricate regulatory network between long non-coding RNAs (lncRNAs) and TGF-β signaling in prostate cancer.
• To discuss the potential of this lncRNA-TGF-β axis in the diagnosis, prognosis, and treatment of PCa.
• To highlight the need for further research into the role of lncRNAs within the TGF-β pathway for understanding PCa pathogenesis.

Main Methods:

• Literature review and synthesis of existing research on TGF-β signaling, lncRNAs, and prostate cancer.
• Analysis of the interplay between TGF-β pathway components and lncRNA expression in PCa.
• Discussion of potential therapeutic and diagnostic strategies targeting the lncRNA-TGF-β network.

Main Results:

• Dysregulated TGF-β signaling is a critical driver of PCa progression and CRPCa.
• lncRNAs are regulated by TGF-β signaling and play a role in PCa.
• The lncRNA-TGF-β interaction presents novel avenues for PCa management.

Conclusions:

• The complex interplay between lncRNAs and TGF-β signaling is fundamental to prostate cancer pathogenesis.
• Targeting this network holds promise for developing innovative diagnostic and therapeutic approaches for PCa.
• Further investigation into lncRNAs within the TGF-β pathway is essential for advancing PCa research and patient care.